Sterling Capital Management’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-50,090	Closed	-$6.56M	–	947
2019 Q2	$6.56M	Buy	+50,090	New	+$6.46M	0.06%	223
2018 Q4	–	Sell	-32,797	Closed	-$4.56M	–	954
2018 Q3	$4.56M	Buy	32,797 +6,933	+27%	+$870K	0.04%	253
2018 Q2	$3.21M	Buy	25,864 +2,982	+13%	+$349K	0.03%	303
2018 Q1	$2.55M	Buy	22,882 +10,009	+78%	+$1.2M	0.02%	353
2017 Q4	$1.54M	Buy	12,873 +10,697	+492%	+$1.3M	0.01%	473
2017 Q3	$306K	Buy	+2,176	New	+$296K	﹤0.01%	826
2017 Q1	–	Sell	-1,992	Closed	-$244K	–	1026
2016 Q4	$244K	Buy	+1,992	New	+$244K	﹤0.01%	880
2016 Q2	–	Sell	-1,880	Closed	-$261K	–	1016
2016 Q1	$261K	Buy	+1,880	New	+$276K	﹤0.01%	836
2015 Q1	–	Sell	-6,146	Closed	-$1.14M	–	981
2014 Q4	$1.14M	Sell	6,146 -10,541	-63%	-$1.95M	0.01%	625
2014 Q3	$2.77M	Sell	16,687 -5,291	-24%	-$869K	0.03%	277
2014 Q2	$3.43M	Sell	21,978 -7,070	-24%	-$1.12M	0.03%	216
2014 Q1	$4.42M	Sell	29,048 -3,952	-12%	-$628K	0.04%	185
2013 Q4	$4.38M	Buy	+33,000	New	+$3.96M	0.04%	178